North Korea’s Nuclear Weapons, and More from CRS
New and updated reports from the Congressional Research Service obtained by Secrecy News that have not been made readily available to the public include the following.
North Korea’s Nuclear Weapons: Technical Issues, February 12, 2013
Pakistan’s Nuclear Weapons: Proliferation and Security Issues, February 13, 2013
Comprehensive Nuclear-Test-Ban Treaty: Background and Current Developments, February 12, 2013
Filling U.S. Senate Vacancies: Perspectives and Contemporary Developments, February 13, 2013
Child Well-Being and Noncustodial Fathers, February 12, 2013
Abortion and Family Planning-Related Provisions in U.S. Foreign Assistance Law and Policy, February 12, 2013
Latin America and the Caribbean: Key Issues for the 113th Congress, February 8, 2013
U.S. Manufacturing in International Perspective, February 11, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.